Work-related cancers are highly preventable. The primary responsibility for prevention rests not with the workers who are affected by cancers, but with the manufacturers and distributors of carcinogenic substances and the companies who use them. U.S. public policies of strict product liability and the Occupational Safety and Health Act of 1970 address the issue of responsibility. Workers, health care providers, and others also have important roles that complement employers' preventive efforts. The range of prevention strategies available includes ones that should be applied to prevent potentially carcinogenic substances from being marketed and distributed; others that apply in the workplace where potential carcinogens are used; and public policy interventions aimed at ensuring universal implementation of pre-market and workplace prevention strategies. Work-related cancer remains a large problem, even though strategies exist to identify carcinogens and prevent and control on-the-job exposures. However, preventive efforts by government and the society have stalled and a continuing lack of toxicity information shows inadequate societal commitment. The principal barriers to prevention of work-related cancers are political and economic rather than scientific and medical.
Get full access to this article
View all access options for this article.
References
1.
StellmanJ. M. and StellmanS. D., Cancer and the Workplace, CA-A Cancer Journal for Clinicians, 46:2, pp. 70–92, 1996.
2.
StellmanJ. M. (ed.), Encyclopaedia of Occupational Health and Safety, International Labour Organization, Geneva, 4 V, 1998.
3.
DiNardiS. R. (ed.), The Occupational Environment: Its Evaluation and Control, American Industrial Hygiene Association Press, Fairfax, Virginia, 1997.
4.
LevyB. S. and WegmanD. H. (eds.), Occupational Health: Recognizing and Preventing Work-Related Disease and Injury (4th Edition), Lippincott Williams and Wilkins, Philadelphia, 2000.
5.
HalperinW. and BakerE. L. (eds.), Public Health Surveillance, Van Nostrand Reinhold, New York, 1992.
6.
MurrayL., Occupational Health, in Introduction to Environmental Health (2nd Edition), BlumenthalD. and RuttenberA. J. (eds.), Springer Publishing Co., Inc., New York, pp. 275–319, 1995.
7.
WaldronH. A., A Brief History of Scrotal Cancer, British Journal of Industrial Medicine, 40, pp. 390–401, 1983.
8.
LandriganP.MarkowitzS., and NicholsonW., Cancer Prevention in the Workplace, in Cancer Prevention and Control, GreenwaldP.KramerS. K.WeedD. L. (eds.), Marcel Dekker, Inc., New York, pp. 33–410, 1995.
9.
AshfordN. and CaldartC., Technology, Law and the Working Environment, Island Press, Washington, D.C., 1996.
10.
SellersC., Discovering Environmental Cancer: Wilhelm Hueper, Post World War II Epidemiology and the Vanishing Clinician's Eye, American Journal of Public Health, 87, pp. 1824–1835, 1997.
11.
InfanteP., Viewpoint: Prevention versus Chemophobia: A Defence of Rodent Carcinogenicity Tests, Lancet, 337, pp. 538–540, 1991.
12.
LandriganP., Cancer Research in the Workplace, in President's Cancer Panel Meeting, National Institutes of Health, Bethesda, Maryland, pp. 224–232, 1993.
13.
LeightJ. P.MarkowitzS. B.FahsM., Occupational Injury and Illness in the United States. Estimates of Costs, Morbidity, and Mortality, Archives of Internal Medicine, 157, pp. 1557–1568, 1997.
14.
SiemiatyckiJ., Future Etiologic Research in Occupational Cancer, Environmental Health Perspectives, 103(Suppl 8), pp. 209–215, 1995.
15.
EDF, Toxic Ignorance: The Continuing Absence of Basic Health Testing for Top-Selling Chemicals in the United States, Environmental Defense Fund, New York, 1997.
16.
LavelleM., EPA's Amnesty Has Become a Mixed Blessing, National Law Journal, pp. A1–A18, 1997.
17.
National Research Council (NRC), Toxicity Testing—To Determine Needs and Priorities, National Academy Press, Washington, D.C., 1984.
18.
WegmanD. H. and LevyB. S., Preventing Occupational Disease, in Occupational Health: Recognizing and Preventing Work-Related Disease, WegmanD. H. and LevyB. S. (eds.), Little, Brown, and Company, Boston, Massachusetts, pp. 83–101, 1995.
19.
EllenbeckerM. J., Engineering Controls as an Intervention to Reduce Worker Exposure, American Journal of Industrial Medicine, 29, pp. 303–307, 1996.
20.
OTA, Chapter 5: Technologies for Controlling Work-Related Illness, in Preventing Illness and Injury in the Workplace, U.S. Congress, Office of Technology Assessment, Washington, D.C., pp. 175–185, 1985.
21.
LaMontagneA. D. and KelseyK. T., OSHA's Renewed Mandate for Regulatory Flexibiltiy Review: In Support of the 1984 Ethylene Oxide Standard, American Journal of Industrial Medicine, 34, pp. 95–104, 1998.
22.
ConeJ. E. and RosenbergJ., Medical Surveillance and Biomonitoring for Occupational Cancer Endpoints, Occupational Medicine State of the Art Reviews, 5, pp. 563–581, 1990.
23.
Institute of Medicine, Role of the Primary Care Physician in Occupational and Environmental Medicine, National Academy Press, Washignton, D.C., 1988.
24.
RobinsonJ. C. and PaxmanD. G., Public Health and the Law: OSHA's Four Inconsistent Carcinogen Policies, American Journal of Public Health, 81, pp. 775–780, 1991.
25.
MichaelsD., When Science Isn't Enough: Wilhelm Hueper, Robert A. M. Case, and the Limits of Scientific Evidence in Preventing Occupational Bladder Cancer, International Journal of Occupational and Environmental Health, 1, pp. 278–288, 1995.
26.
GriefeA.HalperinW.GroceD.O'BrienD.PedersenD.MyersJ. R., and JenkinsL., Hazard Surveillance: Its Role in Primary Prevention of Occupational Disease and Injury, Applied Occupational and Environmental Hygiene, 10, pp. 737–742, 1995.
27.
InfanteP. F., Cancer and Blue-Collar Workers: Who Cares?New Solutions5, pp. 52–57, 1995.
28.
NIOSH, National Occuational Research Agenda, U.S. Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, Bethesda, Maryland, 1996.
29.
KarjalainenA., Asbestos—A Continuing Concern, Scandinavian Journal of Work Environmental Health, 23, pp. 81–82, 1997.
30.
GomezM. R., Recommendations for Optimizing the Usefulness of Existing Exposure Databases for Public Health Applications, American Industrial Hygiene Association Journal, 58, pp. 181–182, 1997.
31.
MarkowitzS. B., The Role of Surveillance in Occupational Health, in Environmental and Occupational Medicine, RomW. N. (ed.), Lippincott-Raven Publishers, Philadelphia, Pennsylvania, pp. 19–29, 1998.
32.
LaMontagneA. D.HerrickR.F.Van DykeM. V.MartynyJ. W., and RuttenberA. J., Exposure Databases and Exposure Surveillance: Promise and Practice, American Industrial Hygiene Association Journal, 63, pp. 205–212, 2002.
33.
FahsM. C.MarkowitzS. B.LeighJ. P., A National Estimate of the Cost of Occupationally Related Disease in 1992, Annals of the New York Academy of Science, 837, pp. 440–455, 1997.
34.
PearceN.MatosE.VainioJ.BoffettaP., and KogevinasM. (eds.), Occupational Cancer in Developing Countries, International Agency for Research on Cancer, Lyon, 1994.
35.
WalshD.JenningsS. E.MangioneT., Health Promotion versus Health Protection? Employees' Perceptions and Concerns, Journal of Public Health Policy, 12, pp. 148–164, 1991.
36.
SorensenG.HimmelsteinJ. S.HuntM. K., A Model for Worksite Cancer Prevention: Integration of Health Protection and Health Promotion in the Wellworks Project, American Journal of Health Promotion, 10, pp. 55–62, 1995.
37.
HeaneyC. and GoldenharL., Worksite Health Programs: Working Together to Advance Employee Health, Health Education Quarterly, 23, pp. 133–136, 1996.
38.
SorensenG.StoddardA.LaMontagneA. D.HuntM. K.EmmonsK.YoungstromR.McLellanD., and ChristianiD. C., A Comprehensive Worksite Cancer Prevention Intervention: Behavior Change Results from a Randomized Controlled Trial in Manufacturing Worksites, Cancer Causes & Control, 13, pp. 493–502, 2002.
39.
LaMontagneA.YoungstromR.LewitonM.StoddardA.McLellanD.WallaceL.BarbeauE., and SorensenG., Assessing and Intervening on OSH Programs: Effectiveness Evaluation of the Wellworks-2 Intervention in 15 Manufacturing Worksites, Occupational Environmental Medicine (in review).
